| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/18/1993 | WO1993002669A1 Transdermal therapeutic systems |
| 02/18/1993 | WO1993002668A1 Microencapsulated quaternary ammonium compounds |
| 02/18/1993 | WO1993002664A1 W/o microemulsions |
| 02/18/1993 | WO1993002660A1 Emulsifier concentrates |
| 02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | CA2114537A1 Transdermal therapeutic systems |
| 02/18/1993 | CA2114240A1 Buffered formulation of peg-sod |
| 02/18/1993 | CA2114141A1 W/o microemulsions |
| 02/18/1993 | CA2113837A1 Anti-hiv agent |
| 02/17/1993 | EP0527638A1 Compositions comprising diltiazem in sustained release form and hydrochlorothiazide in immediate release form |
| 02/17/1993 | EP0527637A1 Spheroids containing dittiazem and a spheronizing agent |
| 02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
| 02/17/1993 | EP0452457A4 Method of in vivo delivery of functioning foreign genes |
| 02/17/1993 | CN1069124A Antibodies and method for their use |
| 02/17/1993 | CN1068966A Core of buccal medicinal health products and its producing method |
| 02/16/1993 | US5187233 Process for emulsion polymerization of graft copolymers |
| 02/16/1993 | US5186939 Laminated composite for transdermal administration of fentanyl |
| 02/16/1993 | US5186936 Packing material for treatment of infections |
| 02/16/1993 | US5186930 Sustained release oral suspensions |
| 02/16/1993 | CA1313619C Percutaneous absorption enhancers, compositions containing same and method of use |
| 02/16/1993 | CA1313617C Compositions for therapeutic percutaneous embolization and the use thereof |
| 02/16/1993 | CA1313602C Flour, bread, milk, and other products from white sweet potatoes, cassava, edible aroids, amaranth, yams, and lotus |
| 02/13/1993 | CA2075356A1 Pharmaceutical spheroid formulation |
| 02/13/1993 | CA2075355A1 Pharmaceutical combination formulation |
| 02/11/1993 | DE3051165C2 Nonionic surfactant mixt. for cosmetic and pharmaceutical compsns. - more easily dispersible with better emulsifying property |
| 02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
| 02/10/1993 | EP0526888A2 Monoclonal antibody reactive with human pancreas cancer tissue |
| 02/10/1993 | EP0526865A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery |
| 02/10/1993 | EP0526700A2 Drug-containing protein-bonded liposome |
| 02/10/1993 | EP0526695A1 Stabilized PVP-I solutions |
| 02/10/1993 | EP0526649A1 Carboxymethylmannoglucan and derivative thereof |
| 02/10/1993 | EP0526578A1 Composition and method for topical treatment of damaged or diseased tissue |
| 02/10/1993 | EP0526481A1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations. |
| 02/10/1993 | CN1068813A Pleuromutilin complexes |
| 02/10/1993 | CN1068744A Asialoglycoprotein-conjugated medicinal agent |
| 02/10/1993 | CN1068739A Improved oral dosing formulations of dideoxy purine nucleosides |
| 02/10/1993 | CN1068736A Process for preparing antifungal composition for external application |
| 02/10/1993 | CN1068735A Stable compositions for parenteral adiministration and thier use |
| 02/09/1993 | US5185444 Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| 02/09/1993 | US5185434 Prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units |
| 02/09/1993 | US5185433 Cross-linking protein compositions having two or more identical binding sites |
| 02/09/1993 | US5185373 Inhibition of thermal degradation of ibuprofen |
| 02/09/1993 | US5185372 Sealed container of solution of retinol palmitate, boric acid, nonionic surfactant, chelating agent, preservative; adjusted pH; topical treatment of dry eye syndrome |
| 02/09/1993 | US5185319 Administering a mixture of insulin and a 30hydroxypyrid-4-one |
| 02/07/1993 | CA2075343A1 Monoclonal antibody and uses of the same |
| 02/06/1993 | CA2075340A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002105A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | WO1993001835A1 Stabilized human monoclonal antibody preparation |
| 02/04/1993 | WO1993001814A1 Oxicam or oxicam derivatives-containing ophthalmic compositions |
| 02/04/1993 | WO1993001811A1 Method of preparing a sterile-filterable solution of an active substance |
| 02/04/1993 | WO1993001802A1 Composition for the sustained and controlled release of a medicinal peptide-containing substance, and preparation method therefor |
| 02/04/1993 | WO1993001799A1 Process for the manufacture of bioerodible poly(orthoester)s and polyacetals |
| 02/04/1993 | WO1993001798A1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses |
| 02/04/1993 | WO1993001746A1 Electrically conductive gel composition |
| 02/04/1993 | WO1993000064A3 Evaluation and treatment of the multidrug resistance phenotype |
| 02/04/1993 | WO1992022332A3 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 02/04/1993 | WO1992019281A3 New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance |
| 02/04/1993 | WO1992019213A3 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy |
| 02/04/1993 | DE4210165A1 Transdermale therapeutische systeme Transdermal therapeutic systems |
| 02/04/1993 | DE4125332A1 Emulgatorkonzentrat Emulsifying |
| 02/04/1993 | CA2113578A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | CA2113542A1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2113185A1 The preparation of an active substance solution which can be sterilized by filtration |
| 02/03/1993 | EP0525992A2 Cluster conjugates of drugs with antibodies |
| 02/03/1993 | EP0525813A1 Water-soluble composition for sustained-release |
| 02/03/1993 | EP0525388A1 Suckable or chewable tablet |
| 02/03/1993 | EP0525307A1 Stable compositions for parenteral administration and their use |
| 02/03/1993 | EP0525199A1 Composition containing ultrafine particles of magnetic metal oxide |
| 02/03/1993 | EP0525177A1 Unimolecular micelles and method of making the same |
| 02/03/1993 | EP0525132A1 Binding of recognizing substances to liposomes. |
| 02/03/1993 | EP0525119A1 Antibody conjugates for treatment of neoplastic disease |
| 02/03/1993 | EP0524987A1 Eriodictyon drug delivery systems |
| 02/03/1993 | EP0524981A1 Eriodictyon extract pharmaceutical compositions |
| 02/03/1993 | EP0517740A4 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
| 02/02/1993 | US5183904 Hindered linking agents and methods |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183883 Conjugate of adriamycin and cyclodextrin |
| 02/02/1993 | US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
| 02/02/1993 | US5183809 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface |
| 02/02/1993 | US5183802 Mixed with nontoxic effective amount of adsorption enhancer-ammonium glycyrrhizinate and a carrier; used as nose sprays for treatment of osteoporosis |
| 02/02/1993 | US5183746 Formulation processes for pharmaceutical compositions of recombinant β- |
| 02/02/1993 | US5183666 Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing |
| 02/02/1993 | US5183662 Controlled drug release composition |
| 02/02/1993 | US5183660 Drugs having decreased antigenicity, delayed biological clearance and exhibit physiological activity over a long period |
| 02/02/1993 | US5183653 Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds |
| 02/02/1993 | US5183589 Stable emulsions of perfluoropolyethers |
| 02/02/1993 | CA2075152A1 Method of preventing a decrease in sweetness of thaumatin |
| 02/02/1993 | CA2075005A1 Water-soluble composition for sustained-release |
| 02/02/1993 | CA1313352C Transdermal drug delivery device with dual permeation enhancers |
| 01/28/1993 | DE4223282A1 Zubereitung zur stetigen und kontrollierten abgabe von medikamentoesen substanzen und verfahren zu deren herstellung Preparation for continuous and controlled release of medicamentous substances and processes for their preparation |
| 01/28/1993 | DE4124252A1 Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung Process for the preparation of a sterilized by drug-spoon |
| 01/27/1993 | EP0524831A1 Process for the manufacture of bioerodible poly(ortho esters) and polyacetals |
| 01/27/1993 | EP0524768A2 Ribotoxins, conjugates thereof ans pharmaceutical composition |
| 01/27/1993 | EP0524718A1 Polyurethane hydrogel compositions for iontophoretic drug delivery |
| 01/27/1993 | EP0524696A1 Oral compositions containing dapiprazole |
| 01/27/1993 | EP0524633A2 Pharmaceutical composition suitable for influencing the reticuloendothelial system |
| 01/27/1993 | EP0524632A1 Pleuromutilin complexes |
| 01/27/1993 | EP0524612A2 Modified silicone containing hair cosmetic |